PULMONX CORP's ticker is LUNG and the CUSIP is 745848101. A total of 102 filers reported holding PULMONX CORP in Q4 2020. The put-call ratio across all filers is - and the average weighting 1.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $208,945 | -21.2% | 20,227 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $265,176 | +17.3% | 20,227 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $226,138 | +32.6% | 20,227 | 0.0% | 0.00% | +100.0% |
| Q4 2022 | $170,514 | -49.4% | 20,227 | 0.0% | 0.00% | -66.7% |
| Q3 2022 | $336,982 | +26.7% | 20,227 | +12.0% | 0.00% | +50.0% |
| Q2 2022 | $265,887 | -32.1% | 18,063 | +14.4% | 0.00% | -33.3% |
| Q1 2022 | $391,775 | +22.6% | 15,791 | +58.5% | 0.00% | 0.0% |
| Q4 2021 | $319,513 | -10.9% | 9,963 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $358,469 | -18.4% | 9,963 | 0.0% | 0.00% | -25.0% |
| Q2 2021 | $439,568 | +80.3% | 9,963 | +86.9% | 0.00% | +100.0% |
| Q1 2021 | $243,840 | -33.7% | 5,331 | 0.0% | 0.00% | -50.0% |
| Q4 2020 | $367,946 | – | 5,331 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ABG-WTT Global Life Science Capital Partners GP Ltd | 60,204 | $1,494,000 | 12.13% |
| Miura Global Management | 595,000 | $14,762,000 | 4.80% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,695,341 | $91,681,000 | 2.05% |
| Millrace Asset Group, Inc. | 78,859 | $1,956,000 | 1.42% |
| NEXT CENTURY GROWTH INVESTORS LLC | 436,034 | $10,818,000 | 1.08% |
| Novo Holdings A/S | 410,155 | $10,176,000 | 0.54% |
| PURA VIDA INVESTMENTS, LLC | 589,722 | $14,631,000 | 0.47% |
| Rock Springs Capital Management LP | 702,400 | $17,427,000 | 0.44% |
| RTW INVESTMENTS, LP | 798,255 | $19,805,000 | 0.41% |
| Regis Management CO LLC | 82,070 | $2,036,000 | 0.36% |